Gastrointestinal, hepatobiliary, breast and thyroid diseases
Conditions
Interventions
control group:Clinical pharmacists do not interfere with the use of proton pump inhibitors
experimental group:Clinical pharmacists intervene in the use of proton pump inhibitors
Sponsors
The Second Affiliated Hospital of Fujian Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Inpatients with gastrointestinal, hepatobiliary, pancreatic, breast and thyroid diseases in general surgery department; 2. Inpatients using proton pump inhibitors during hospitalization; 3. Patients with clear consciousness and basic language communication skills.
Exclusion criteria
Exclusion criteria: 1. Inpatient who change the major department(including turn-in and turn-out); 2. The patient has not been discharged from the hospital during the sample period; 3. Patients with tumor chemotherapy; 4. Patients with a history of mental illness,cognitive impairment,or communication disorders; 5. Patients or family members refused to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rationality rate;usage rate of proton pump inhibitors;Drug and proton pump inhibitor costs;Drug Utilization Frequency, Limited Daily Cost and Drug Utilization Index Ranking; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cost;adverse drug event rate;Ratio of recommendation accepted by physician;The rational rate of therapeutic medication and preventive medication; | — |
Countries
China
Contacts
Public ContactZhang Yin
The Second Affiliated Hospital of Fujian Medical University
Outcome results
None listed